Leptin Resistance in Vagal Afferent Neurons Inhibits Cholecystokinin Signaling and Satiation in Diet Induced Obese Rats by de Lartigue, Guillaume et al.
Leptin Resistance in Vagal Afferent Neurons Inhibits
Cholecystokinin Signaling and Satiation in Diet Induced
Obese Rats
Guillaume de Lartigue, Claire Barbier de la Serre, Elvis Espero, Jennifer Lee, Helen E. Raybould*
Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, California, United States of America
Abstract
Background and Aims: The gastrointestinal hormone cholecystokinin (CCK) plays an important role in regulating meal size
and duration by activating CCK1 receptors on vagal afferent neurons (VAN). Leptin enhances CCK signaling in VAN via an
early growth response 1 (EGR1) dependent pathway thereby increasing their sensitivity to CCK. In response to a chronic
ingestion of a high fat diet, VAN develop leptin resistance and the satiating effects of CCK are reduced. We tested the
hypothesis that leptin resistance in VAN is responsible for reducing CCK signaling and satiation.
Results: Lean Zucker rats sensitive to leptin signaling, significantly reduced their food intake following administration of
CCK8S (0.22 nmol/kg, i.p.), while obese Zucker rats, insensitive to leptin, did not. CCK signaling in VAN of obese Zucker rats
was reduced, preventing CCK-induced up-regulation of Y2 receptor and down-regulation of melanin concentrating
hormone 1 receptor (MCH1R) and cannabinoid receptor (CB1). In VAN from diet-induced obese (DIO) Sprague Dawley rats,
previously shown to become leptin resistant, we demonstrated that the reduction in EGR1 expression resulted in decreased
sensitivity of VAN to CCK and reduced CCK-induced inhibition of food intake. The lowered sensitivity of VAN to CCK in DIO
rats resulted in a decrease in Y2 expression and increased CB1 and MCH1R expression. These effects coincided with the
onset of hyperphagia in DIO rats.
Conclusions: Leptin signaling in VAN is required for appropriate CCK signaling and satiation. In response to high fat feeding,
the onset of leptin resistance reduces the sensitivity of VAN to CCK thus reducing the satiating effects of CCK.
Citation: de Lartigue G, Barbier de la Serre C, Espero E, Lee J, Raybould HE (2012) Leptin Resistance in Vagal Afferent Neurons Inhibits Cholecystokinin Signaling
and Satiation in Diet Induced Obese Rats. PLoS ONE 7(3): e32967. doi:10.1371/journal.pone.0032967
Editor: Silvana Gaetani, Sapienza University of Rome, Italy
Received October 10, 2011; Accepted February 6, 2012; Published March 7, 2012
Copyright:  2012 de Lartigue et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Work funded by National Institutes of Health DK41004. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: heraybould@ucdavis.edu
Introduction
Under normal physiological conditions, the presence of fat in
the small intestine stimulates the release of gut hormones,
including cholecystokinin (CCK) and peptide YY (PYY) [1,2],
thereby slowing gastric emptying [3] and suppressing food intake
[1]. Paradoxically, chronic consumption of a high fat diet (HFD)
results in hyperphagia and obesity [4,5]. There is evidence that
obesity in both humans [6] and rats [7] results in reduced
sensitivity to the satiating effect of lipids compared to their lean
counterparts. This does not appear to occur as a result of reduced
release of CCK [2], but rather to a reduction in sensitivity to the
satiating effects of CCK [8–10]. The mechanisms leading to the
decrease in response to CCK remain unknown, although it seems
to occur independently of CCK1 receptor (CCK1R) expression
[11].
CCK, released from the small intestine in response to fatty acids
and proteins, activates CCK1R located on vagal afferent nerve
terminals in the gut to inhibit gastric emptying and food intake,
and stimulating pancreatic enzyme secretion and gall bladder
contraction. In addition to stimulating the discharge of vagal
afferent neurons (VAN), CCK also changes the neurochemical
phenotype of VAN. The change in neurochemical phenotype is
characterized by altered expression levels of G-protein coupled
receptors and neuropeptide transmitters. Following feeding or
administration of exogenous CCK, the peptide YY type 2 (Y2)
receptor [12] and the anorexigenic neuropeptide transmitter
cocaine and amphetamine regulated transcript (CART) [13] are
upregulated; synthesis of the orexigenic neuropeptide transmitter
melanin-concentrating hormone (MCH) [13,14] as well as the
MCH1 receptor (MCH1R) [14] and CB1 receptor (CB1) [15] are
inhibited. Conversely, fasting, or feeding in the presence of a
CCK1R antagonist, decreases expression of CART and Y2, and
increases MCH, MCH1R and CB1 expression in VAN. This
suggests that CCK acts as the ‘‘gatekeeper’’ in the control of the
neurochemical phenotype in VAN and can influence food intake
and GI function both rapidly, by stimulating action potentials, or
induce prolonged effects, by regulating the expression of proteins
known to play a role in the control of feeding behavior.
The long form of the leptin receptor has been found to be co-
expressed with CCK1R in a subset of VAN [16–18]. Leptin alone
rapidly increases VAN discharge [19,20] and increases cytosolic
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32967calcium in culture [21]. However, leptin also plays a crucial role in
modulating the sensitivity of these neurons to CCK. Leptin
markedly enhances vagal afferent discharge [20], cytosolic calcium
[21,22], and translocation of the early gene EGR-1 to the nucleus
[23] in response to low doses of CCK. Leptin regulates EGR-1
levels while CCK activates EGR-1 in VAN. Inhibition of EGR-1
abolishes leptin-induced sensitization of VAN to CCK and reduces
CCK-induced expression of CART in VAN [23]. Vagally-
mediated changes in function, such as inhibition of food intake
and gastric emptying in response to CCK, are also enhanced by
leptin [23,24].
We have recently demonstrated that chronic ingestion of a high
fat diet leads to the development of leptin resistance in VAN of diet-
induced obese rats, compared to low fat fed control rats or rats
resistant to the obesigenic effects of a high fat diet [4]. In the present
study, we hypothesize that leptin resistance in VAN of DIO rats is
responsible for the reduced sensitivity of these neurons to CCK,
resulting in an altered neurochemical phenotype in VAN and
hyperphagia. Firstly, Zucker rats which have a genetic deletion of
theleptinreceptorwereused todeterminetheeffectof altered leptin
function on VAN. Secondly, Sprague-Dawley rats with a
predisposition to diet-induced obesity (DIO), that develop leptin
resistance in VAN when fed a HF diet [4], were used to determine
changes in CCK-induced inhibition of food intake and signaling in
VAN in response to long term ingestion of a high fat diet.
Results
Reduced sensitivity of VAN to CCK in obese Zucker rats
Initial studies using Zucker rats demonstrated that leptin
signaling is required for CCK-induced activation of VAN and
its subsequent anorexigenic effects. Zucker rats are a genetic
model of leptin receptor deficiency [25,26]. As previously
reported, homozygous Zucker rats (LepR
fa/LepR
fa), weighed
significantly more than lean Zucker rats when fed on chow
(p,0.01; Fig. 1A). Exogenous leptin (4.94 nmol/kg; i.p.) phos-
phorylated STAT3 in the nodose ganglia and arcuate nucleus of
lean Zucker rats; however as expected, leptin had no effect on
STAT3 phosphorylation in either arcuate or vagal afferent
neurons from obese Zucker rats (Fig. 1B–E).
To determine whether CCK-induced inhibition of food
intake requires leptin signaling, food intake in fasted lean and
obese Zucker rats was measured following administration of
CCK8S (i.p.; 0.22 nmol/kg). In lean Zucker rats, CCK
induced a 25% reduction in food intake compared to saline;
CCK had no effect on food intake in obese Zucker rats
(Fig. 1F).
To determine whether leptin signaling is required in the
regulation of the neurochemical phenotype of VAN, immunore-
activity of Y2, MCH1R and CB1 was examined in the nodose
ganglia of lean and obese Zucker rats in the presence or absence of
Figure 1. Altered CCK induced satiety in obese Zucker rats. A) Obese Zucker rats weigh significantly more than lean Zucker rats (N=12; t-
test). B) Immunoblot of pSTAT3 in VAN of lean (top) and obese (bottom) Zucker rats treated with vehicle or leptin. C) Densitometry analysis of B
showing that STAT3 is phosphorylated in response to leptin (i.p) in VAN of lean Zucker rats but not in obese Zucker rats. N=4 D) Immunoblot of
pSTAT3 in hypothalamus of lean and obese Zucker rats treated with leptin. E) Densitometry analysis of D showing that STAT3 is phosphorylated in
response to leptin in the arcuate nucleus of the hypothalamus of lean Zucker rats, but not obese Zucker rats. (N=4).F) CCK8S (i.p., 0.22 nmol/kg)
significantly inhibited food intake in lean Zucker rats but not obese Zucker rats. N=6. Data expressed as mean 6 SEM. Significant differences were
represented as
a,b,c between groups in one-way ANOVA. Significant differences were represented as * for p,0.05; ** for p,0.01; and *** for p,0.001
in Student’s t-test.
doi:10.1371/journal.pone.0032967.g001
Mechanism of Onset of Hyperphagia in Obese Rats
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phenotype of VAN was low levels of Y2 expression and high
levels of MCH1R and CB1 (Fig. 2); feeding (which releases CCK)
increased Y2 expression and decreased MCH1R and CB1
expression (Fig. 2). In fasted obese Zucker rats, expression levels
of Y2, CB1 and MCH1R were similar to that observed in fasted
lean Zucker rats; however, feeding failed to up-regulate Y2
expression (Fig. 2A,P .0.05), or down-regulate MCH1R expres-
sion in VAN (Fig. 2B;p .0.05). CB1 expression was down-
regulated in VAN of fasted obese Zucker rats (Fig. 2C;p ,0.05),
but was still significantly elevated compared to fasted lean Zucker
rats (Fig. 2C;p ,0.01).
Figure 2. Altered CCK induced signaling in obese Zucker rats. Photomicrographs of sections of nodose ganglia to show immunoreactivity for
Y2 (A), MCH1R (B), and CB1 (C) from lean and obese Zucker rats fasted 24 hr or refed for 1 hr. A) Y2 expression is elevated by feeding in lean Zucker
rats, but not in obese Zucker rats. N=4. B) MCH1R is decreased by feeding in lean Zucker rats but not in obese Zucker rats. N=4. C) CB1 is decreased
by feeding in lean and obese Zucker rats, but CB1 expression remains significantly higher in fed obese Zucker rats compared to lean Zucker rats.
Significant differences were represented as
a,b,c between groups.
doi:10.1371/journal.pone.0032967.g002
Mechanism of Onset of Hyperphagia in Obese Rats
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Sprague Dawley rats carry a polygenic susceptibility to high fat
diet-induced obesity; individuals become either diet-induced obese
(DIO) or remain lean (diet-induced obese resistant DR) when
ingesting high fat diet [27]. We have recently demonstrated that
chronic (8 week) ingestion of a high fat diet leads to the
development of leptin resistance in VAN of DIO, but not in DR
or low fat (LF) fed control rats, and that this occurs in the absence
of measurable leptin resistance in the arcuate nucleus of the
hypothalamus [4]. Hence this rat model was used to determine
whether leptin signaling in VAN is required for CCK-signaling
and its subsequent anorexigenic effects.
A total of 24 Sprague Dawley rats were fed a HF diet for 8
weeks. Rats with the highest body weight at 8 weeks were assigned
to the DIO group (n=12), the other rats were designated DR
(n=12). After 8 weeks, DIO rats had significantly higher body
weight compared to either LF fed controls rats or DR rats
(p,0.01, Fig. 3A); there was no significant difference between DR
and LF controls (p.0.05). DIO rats had a significantly higher body
weight gain after 4 weeks on a HF diet compared to both the DR
and LF controls (p,0.01; p,0.001, respectively; Fig. 3B).
In the first week on a HF diet, both DIO and DR groups had a
higher caloric intake than LF fed controls (p,0.001). Following
acclimation to the HF diet in the first week, DR rats had equal caloric
intake to the LF fed controls. DIO rats had a consistently higher
caloric intake than either LF and DR rats but this only reached
significance after 5 weeks (p,0.001, p,0.01, respectively, Fig. 3C).
Leptin resistance in VAN decreases CCK-induced
inhibition of food intake
Administration of CCK8S (i.p., 0.22 nmol/kg) after 12 hr
fasting reduced food intake by 27% in LF and DR rats compared
to saline (Fig. 4A;p ,0.01) but had no effect in DIO rats (Fig. 4A;
p.0.05). However, a higher dose of CCK8S (i.p., 2.19 nmol/kg)
significantly reduced food intake in DIO as well as LF and DR rats
compared to saline (Fig. 4B;p ,0.01).
To determine whether leptin resistance in VAN of DIO rats would
inhibit the satiating effects of endogenous CCK, we used a previously
described feeding protocol in which a small preload meal was used to
release endogenous CCK [23]. In this protocol we found that
exogenous leptin had no effect on food intake in fasted rats. After a
preload meal (which increases endogenous CCK), we observed that
exogenous leptin inhibited food intake, and these effects were
abolished by a CCK1R antagonist, lorglumide [23]. Therefore, we
concluded that leptin potentiates the satiating effects of endogenous
CCK. Here we show using this same protocol (Fig. 4C) that after 4
weeks on the respective diets, leptin significantly potentiated CCK-
induced inhibition of food intake in LF, DR, and DIO rats (LF,
p,0.01; DR, p,0 . 0 1 ;D I O ,p ,0.01; Fig. 4D). After 6 weeks on a HF
diet, DIO rats receiving leptin (i.p.; 4.94 nmol/kg) no longer
significantly inhibited food intake even in the presence of endogenous
release of CCK by a preload meal (LF: p,0.01; DR: p,0.01; DIO:
p.0 . 0 5 ;F i g .4 D). After 8 weeks leptin had no effect on food intake in
DIO rats (LF: p,0.01; DR: p,0.01; DIO: p.0.05; Fig. 4D). In
contrast, LF fed and DR rats after 6 and 8 weeks on LF or HF diets,
respectively, had reduced feeding in response to exogenous leptin
(i.p..; 4.94 nmol/kg) compared to vehicle following the release of
endogenous CCK induced by the preload meal (p,0.01; Fig. 4D).
Leptin resistance in VAN decreases CCK-induced
alteration in neurochemical phenotype
Under fasting conditions, VAN of LF and DR rats expressed
low Y2 abundance while in the fed state Y2 abundance is
Figure 3. Effect of a high-fat (HF) diet on body weight and food
intake A) Body weight of rats ingesting either a LF diet or HF
diet (45% kcal) for 8 weeks. There was a significant increase in body
weight in diet-induced obesity (DIO) rats compared with diet-induced
obesity-resistant (DR) and LF animals. B) The increase in body weight of LF,
DR, DIO rats expressed as a percent of weight gain from initial weight. DIO
rats became significantly heavier than LF fed animals after 4 weeks of HF
diet, and after 4 weeks of a HF diet compared to the DR rats. C)A v e r a g e
daily food intake (kcal) per week over the 8 weeks on the diets. In the first
week, all rats on the HF diet had a significantly higher energy intake than LF
fed rats but this initial hyperphagia only lasted for one week after which
there was no significant difference in caloric intake between the groups. At
week 5, the DIO group had a significantly higher energy intake than LF rats
and DR rats. N=12 per group; data expressed as mean 6 SEM. Significant
differences were represented as
a,b,c between groups.
doi:10.1371/journal.pone.0032967.g003
Mechanism of Onset of Hyperphagia in Obese Rats
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e32967increased as previously described (Fig. 5A) [12]. In contrast, Y2
expression was constitutively low in VAN from DIO rats in the fed
and fasted states (Fig. 5A). Similarly, in LF and DR rats, MCH1R
and CB1 expression was high in VAN from fasted rats and
decreased upon feeding (Fig. 5B–C); however, in DIO rats these
proteins were constitutively expressed even in the fed state
(Fig. 5B–C).
Leptin resistance prevent CCK signaling in VAN
Leptin-induced phosphorylation of the transcription factor
STAT3 is required for EGR-1 expression and EGR-1 is involved
in mediating gene expression [23]. We have previously shown that
leptin resistance (as defined by an absence of phosphorylation of
STAT3 in response to leptin) is present in VAN of DIO rats after 8
weeks of chronic high fat feeding [4]. We hypothesized, therefore,
that the absence of pSTAT3 in leptin-resistant VAN of DIO rats
would result in low EGR-1 abundance. To test this, we measured
EGR-1 levels by western blot in the nodose ganglia of leptin-
treated rats following 8 weeks on the respective diets. EGR-1
expression was high in VAN of both LF and DR rats in response
to leptin (i.p.; 4.94 nmol/kg), but was absent in VAN from DIO
rats (Fig. 6A–B).
Leptin and CCK interact at the level of EGR1 in VAN. To
study these interactions at the cellular level, we cultured VAN of
DR and DIO rats and determined the effect of leptin-resistance on
CCK-induced EGR-1 translocation to the nucleus. In cultured
VAN from DR rats (Fig. 6C), CCK8S alone induced maximal
EGR-1 activation at 10 nM but had little effect at lower doses.
Leptin alone (10 ng/ml) had no effect on EGR-1 nuclear
translocation but significantly increased the number of nuclear
EGR-1-positive neurons in the presence of low doses of CCK
(0.01–1 mM) (Fig. 6C). The dose-dependent response to CCK
alone in VAN of DIO rats (Fig. 6D) was identical to that of VAN
from DR (Fig. 6C) or LF rats [23]. However, the ability of leptin to
act synergistically with CCK in VAN of DIO rats is completely
abolished (Fig. 6D).
Discussion
We have previously shown that VAN from diet-induced obese
rats are leptin-resistant; this leptin resistance occurs only in rats
that express the obese phenotype and not in rats that remain lean
when ingesting a HF diet. Here, we wanted to determine the
consequences of impaired leptin signaling in VAN by studying
EGR-1 signaling in VAN, changes in VAN neurochemical
phenotype in response to feeding, and functional responses on
control of food intake. The data show that in Zucker rats, the lack
of leptin signaling is associated with a complete lack of phenotypic
change of VAN normally induced by feeding and this is associated
with an absence of CCK-induced inhibition of food intake in these
rats. Moreover, in DIO rats, the lack of leptin signaling in VAN,
results in a lack of phenotypic change in VAN in response to
feeding, a decrease in CCK-induced nuclear EGR-1 and a lack of
endogenous CCK-induced inhibition of food intake. Taken
Figure 4. Reduced satiation to exogenous and endogenous
CCK in DIO rats. A) CCK feeding study (described in methods) in
Sprague Dawley rats after 8 weeks on respective diets. CCK8S
(0.22 nmol/kg; i.p.) significantly inhibited food intake compared to
vehicle in LF and DR, but not DIO rats. N=6. B) CCK8S (2.19 nmol/kg;
i.p.) significantly inhibited food intake in all rats. N=6. C) Protocol for
leptin feeding study in which endogenous CCK was upregulated D)
Endogenous CCK reduced food intake in LF fed and DR rats at 4, 6 and 8
weeks. Endogenous CCK reduced food intake in DIO rats at 4 weeks but
not at 6 and 8 weeks. N=6; data expressed as mean 6 SEM. Significant
differences were represented as ** for p,0.01.
doi:10.1371/journal.pone.0032967.g004
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account for the well known decrease in lipid- and CCK-induced
satiation and hyperphagia following chronic HF feeding. Inaccu-
rate monitoring of nutrients in the intestinal lumen may lead to a
lack of satiety and contribute to diet-induced hyperphagia and
obesity.
Figure 5. Altered neurochemical phenotype in DIO rats. Photomicrographs of sections of nodose ganglia to show immunoreactivity for Y2 (A),
MCH1R (B), and CB1 (C) from fed and fasted Sprague Dawley rats after 8 weeks on respective diets. A) Y2 is barely detectable in nodose neurons of LF,
DR, and DIO rats fasted 24 hours. Refeeding for 1 hour increased Y2 expression in LF and DR but not DIO rats. Quantification of positive Y2 cells as a
percent of total cells. B) MCH1R and C) CB1 expression is elevated in fasted rats and is decreased by refeeding for 1 hour in LF and DR but not DIO
rats. Quantification of positive MCH1R and CB1 cells as a percent of total cells. Representative images from experiments with four to six rats in each
group are shown. Significant differences were represented as
a,b,c between groups.
doi:10.1371/journal.pone.0032967.g005
Mechanism of Onset of Hyperphagia in Obese Rats
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signaling in VAN [23,24,28] and leptin has also been found to
potentiate the inhibitory action of CCK on food intake [23,24].
Zucker rats are completely insensitive to leptin as a result of a
single amino acid substitution of a glutamine for a proline in the
leptin receptor gene (Ob-R) [25,29]. Zucker rats homozygous for
the fa gene are morbidly obese and characterized by fat cell
hypertrophy and hyperplasia [30], increased adipose tissue,
lipoprotein lipase activity [31], hyperinsulinemia, hypertriglycer-
idemia, and hyperphagia [32] compared to their lean heterozy-
gous counterparts. Unsurprisingly, we found that exogenous
administration of leptin in these rats failed to phosphorylate
STAT3 in both the arcuate nucleus and the nodose ganglia, while
lean Zucker rats responded normally to leptin. We demonstrate
that loss of leptin signaling in Zucker rats inhibits CCK induced
signaling in VAN and at a dose that inhibits food intake in lean
Zucker rats, CCK failed to inhibit food intake in obese Zucker
rats.
Under normal physiological conditions leptin and CCK interact
at the level of EGR1 in VAN. Leptin upregulates expression of
EGR1 in these neurons, while CCK activates EGR1. Inhibition of
EGR1 abolishes leptin potentiation of CCK-induced protein
synthesis in VAN [23]. Here we demonstrate that altered leptin
signaling, as a result of VAN resistance to leptin following
prolonged ingestion of a HF diet, prevents high EGR1 expression
in VAN. To study the interactions between leptin and CCK at the
cellular level, we used cultured VAN from DR and DIO rats.
Interestingly the dose-dependent translocation of EGR1 to the
nucleus in response to CCK alone in VAN of DIO rats was
identical to that of VAN from DR rats, demonstrating that the
sensitivity of VAN from DIO rats to CCK alone is not changed
(Fig. 6D). However, the ability of leptin to act synergistically with
CCK in the DIO rats is completely abolished. Therefore the
response to CCK is unaltered, but rather the potentiating effect of
leptin on CCK is lost in VAN of DIO rats, suggesting that leptin
activation of VAN is required for optimal CCK signaling.
Similarly, the satiating effects of CCK in DIO rats are not
completely abolished, instead higher concentrations of CCK are
required in these rats to inhibit food intake. Administration of a
low dose of CCK (0.22 nmol/kg) after a 12 hr fast inhibited food
intake in LF and DR rats but had no effect in DIO rats. However,
a 10-fold higher dose of CCK produced a significant reduction in
food intake in both DIO and DR rats. We propose that loss of the
potentiating effects of leptin in DIO rats is responsible for the
reduced sensitivity VAN to CCK signaling and subsequently that
higher concentrations of CCK are required for satiation.
Feeding in the presence of a CCK1 receptor antagonist
completely abolishes feeding induced Y2 expression and inhibition
of MCH1R and CB1, and injection of CCK in fasted animals
increases Y2 and inhibits MCH1R and CB1 [12–15,33,34]
_ENREF_13. Hence, under normal physiological conditions,
CCK is required for the regulation of the neurochemical
phenotype in VAN [13]. Here we found that lean Zucker rats
had high Y2 and low MCH1R and CB1 abundance in VAN;
Figure 6. EGR-1 expression in VAN of DIO rats. A) Protein expression of EGR-1 in VANs of LF, DR and DIO rats treated with leptin. B)
Densitometry analysis of A showing that EGR-1 levels in VAN are significantly reduced in DIO rats compared to LF and DR rats. N=3. C) and D)
Quantification of the number of EGR-1 immunopositive neurons in cultured VAN from DR rats (C) and DIO rats (D) fed a high fat diet for 8 weeks. C)
Leptin reduced the concentration of CCK required to induce EGR-1 translocation in cultured VAN. D) Leptin had no effect on CCK induced EGR-1
translocation in cultured VAN. N=6. Data expressed as mean 6 SEM. Significant differences were represented as
a,b,c between groups.
doi:10.1371/journal.pone.0032967.g006
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low in VAN and feeding failed to inhibit MCH1R and CB1
expression in VAN. Therefore in the absence of leptin signaling,
VAN are unable to alter their neurochemical phenotype in
response to endogenous CCK after a meal.
Similarly, VAN of DIO rats did not respond to feeding,
exhibiting elevated Y2 abundance, as well as reduced MCH1R
and CB1 expression compared to LF or DR rats. DIO rats develop
leptin resistance in VAN, prior to measurable leptin resistance in
the ARC, therefore we conclude that hypothalamic leptin
resistance is not required for CCK induced signaling and satiation.
We hypothesize instead that reduced VAN sensitivity to CCK, as a
result of leptin resistance in these neurons, is responsible for the
altered expression of these receptors and would have important
functional consequences on vagally mediated regulation of food
intake.
Changes in receptor expression on VAN of DIO animals
suggest that the sensitivity of VAN to the gastrointestinal
hormones that bind these receptors will be altered. Reduced Y2
expression in VAN of obese animals would prevent signaling of the
anorexigenic hormone PYY3–36 via VAN in response to a meal.
PYY3–36 is an anorectic peptide released from L cells in response
to a meal which inhibits pancreatic enzyme secretion [35],
influences gastric emptying [36] and inhibits food intake [37].
Subdiaphragmatic vagotomy attenuates the effects of PYY3–36 on
food intake in rats [38,39] suggesting that Y2 receptor downreg-
ulation in VAN of obese animals would prevent the satiating
effects of PYY3–36. Furthermore constitutively high MCH1R and
CB1 expression in VAN of obese animals suggests that
anandamide released from the gut and MCH from VAN would
prolong orexigenic signaling. Thus altered receptor expression
could increase the orexigenic tone of the vagus, potentially
resulting in hyperphagia.
DIO rats develop hyperphagia between weeks 4 and 5 following
chronic HF feeding. In the first 4 weeks, DIO and DR rats
consume the same amount of food, but by week 5 the DIO rats
consume 10 kcal per day more than the DR rats (Fig. 3C).
Interestingly we provide evidence that functional leptin resistance
develops between weeks 4 and 6 of a HF diet, which coincides with
the onset of hyperphagia in these rats (Fig. 4D).
There is evidence in the literature to suggest that altered CCK
sensitivity could result in hyperphagia. Both knockout mice and
OLEFT (Otsuka Long Evans Tokushima Fatty) rats that lack the
CCK1R eat larger meals than their respective controls. Crucially
OLETF (Otsuka Long Evans Tokushima Fatty) rats, which lack
the CCK-1 receptor gene, have increased average meal size, with
reduced meal frequency that is insufficient to compensate for the
increase in meal size, resulting in hyperphagia [40]. Interestingly,
pair feeding OLETF rats with intact controls (LETO rats)
prevented the development of obesity [41]. This suggests that
reduced sensitivity to CCK results in hyperphagia and could
directly lead to the development of obesity.
While mice lacking the CCK1R eat larger and longer meals
both in response to chow or a high fat diet compared to wild type
mice [42], they have statistically insignificant increases in total
daily food intake and maintain normal body weight. The reason
for the difference in response between knockout mice and OLEFT
rats to the absence of CCK1R is not clear. However, it should be
noted that the knockout mice are on a 129S genetic background,
which is known to confer resistance to obesity [43]. Mice with this
genetic background have been reported to have low feeding
efficiency (small weight gain per calorie consumed), and high basal
energy expenditure [44]. Another important difference is that
OLEFT and LETO rats express the NPY gene in the dorsal motor
nucleus of the hypothalamus (DMH) while wild-type and CCK1
receptor
2/2 mice do not. Crucially, DMH NPY gene expression is
dysregulated in OLEFT rats so that in response to a high-fat diet,
NPY expression is significantly reduced in LETO rats but not in
OLETF rats [45].
In conclusion, we demonstrate that the onset of leptin resistance
in VAN of DIO rats results in the reduced sensitivity of VAN to
CCK. This leads to altered expression of receptors in VAN known
to play a role in the regulation of food intake. We hypothesize that
these changes result in increased orexigenic signaling and reduced




All experiments with animals reported complied with relevant
national and international guidelines. All experimental procedures
involving rats complied with an animal studies protocol (#15202)
approved by the UC Davis Institutional Animal Care and Use
Committee (IACUC) and PHS animal welfare assurance to UC
Davis (#A3433-01).
Rats
Male Sprague Dawley rats (initial weight 180 g; Harlan San
Diego, n=36) were housed at 22uC under a 12 h light (6am–
6pm), 12 h dark (6pm–6am) cycle with ad libitum access to food
and water. Rats were kept on chow (13% kcal/g fat; Purina
5001) or high fat (HF) diet (45% kcal/g fat; Research Diets
D12451) for 8 weeks. Body weight and food intake were
measured twice a week. Feeding studies were performed between
weeks 4 and 8. After week 8 on respective diets, rats were fasted
overnight, and were injected the following morning (9–10 am)
either leptin (4.94 nmol/kg, i.p.) or saline (400 ml, i.p.). After 1 h
rats were deeply anesthetized with a mixture of sodium
phenytoin and pentobarbital sodium (0.2 ml/100 g i.p., Beutha-
nasia-D Special C-III; Shering, Kenilworth, NJ) and tissue was
collected.
Male Zucker rats (12 lean and 12 obese; 6 weeks old; Charles
River) were fed chow for three weeks before tissue collection,
during which time all feeding studies were performed.
Feeding studies
Rats were fasted for 12 h starting at 9am. CCK feeding study:
CCK (0.22 nmol/kg or 2.19 nmol/kg; i.p.) or saline (400 ml, i.p.)
were administered and food intake was recorded every 20 min for
2 h. The low dose of CCK was chosen based on work by
Savastano and Covasa [10] demonstrating that DIO rats were
insensitive to this dose of CCK. We selected a 10 times higher dose
to show that DIO rats had reduced sensitivity to CCK rather than
an inability to respond. Leptin feeding study: Leptin (4.94 nmol/
kg; i.p.) or saline (400 ml; i.p.) were administered. Leptin dose was
selected based on previously published work in our laboratory
[4,23]. Animals were allowed to consume 10 kcal of chow for
40 min; food intake was then recorded every 20 minutes for 2 h as
previously described [4]. All rats within each group (LF, DR and
DIO) were paired according to body weight; one rat in each pair
received either vehicle or treatment.
Peptides and drugs
Leptin (rat) was obtained from Sigma (St. Louis, MO).
Cholecystokinin, CCK (octapeptide, sulfated) was purchased from
Bachem (Torrance, CA).
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Nodose ganglia were dissected under aseptic conditions,
desheathed, and digested for 120 min at 37uC in 3 ml of Ca
2+
and Mg
2+ free HBSS containing 6 mg collagenase type Ia (Roche
Diagnostics, Indianapolis, IM) as previously described [46]. Cells
were plated onto four-well chamber slides, and maintained in
HEPES-buffered DMEM with 10% fetal calf serum at 37uCi n
5.5% CO2, and media changed every 24 h. Cells were maintained
in culture for 72 h, at which time they were transferred to serum-
free medium for 1 h before treatment with CCK (0.01–10 nM)
either alone or in combination with leptin (10 ng/ml) for 2 h.
Doses were selected based on previous publications [23].
Immunohistochemistry
Cryostat sections of fixed nodose ganglia (5 mm) were mounted
on polysine-coated slides (Polysine; MenzelGlaser, Braunschweig,
Germany) and processed for immunohistochemistry with an
antibody raised against Y2, MCH1R and CB1 (Santa Cruz
Biotechnology, Santa Cruz, CA). Cultured neurons were fixed in
4% paraformaldehyde in PBS (30 min RT) and processed for
immunocytochemistry with antibodies raised EGR1 (Cell Signal-
ing Technology, Danvers, MA). Secondary antibodies were used
as appropriate and included donkey anti-rabbit immunoglobulin
conjugated with AlexaFluor 488 and donkey anti-goat immuno-
globulin conjugated with AlexaFluor 546 (Molecular Probes,
Eugene, OR). Specificity of immunostaining was determined by
omitting the primary antibody and by pre-incubation with an
excess of appropriate peptide where available. Cultured neurons
were mounted in Vectashield with 49,6-diamidino-2-phenylindole
(DAPI; Vector Laboratories, Peterborough, UK) for nuclear
localization. Images were collected using an Olympus spinning
disc confocal microscope (BX61 System, Olympus, Melville, NY).
The quantification of neurons expressing CB1, MCH1R, or Y2
was made by counting 200–300 immunoreactive cell profiles in
four sections per ganglion, selecting sections separated by 90 mm
that passed through the full length of the caudal and mid regions of
the ganglia. Results are expressed as immunopositive cells as a
proportion of all neurons in the relevant region.
Western blotting
As previously described _ENREF_47 [47], briefly, 10 mgo f
proteins were used, unless otherwise stated in the legends, samples
were loaded into precast 10% BisTris gel and the gel was run for
50 min at 200 V. The proteins were transferred 1 h. Primary
antibodies were left to incubate overnight (STAT3 phosphorylated
at tyrosine 705 (D3A7) Ab and EGR1 Ab, Cell Signaling
Technology). GAPDH was used as a loading control (14C10)
rabbit mAb, Cell Signaling Technology). The film was analyzed
by Imagequant v 5.1 software (Amersham, Biosciences, Amer-
sham, UK).
Statistics
Statistical analysis was performed using Prism software (Prism
5.0, GraphPad Software Inc., La Jolla, CA, USA). Two way
ANOVA was used to analyze energy intake data and leptin
feeding studies (time and diet were used as the variables). One
ANOVA was used to analyze immunohistochemical data. One
way ANOVA was also performed to analyze western blot and
CCK feeding studies with diet used as a variable and differences
among groups were analyzed using multiple comparison proce-
dure (Bonferroni). Differences were considered significant if
p,0.05. Data are mean 6 SEM.
a,b,c different letters denote
significant differences between groups. Unpaired one-tailed
student’s t-test was used to compare lean vs. obese Zucker rats’
body weight and pSTAT3 expression in hypothalamus of these
rats. Paired one-tailed student’s t-test was used to compare the
effects of CCK in LF, DR, and DIO rats. Significant differences
were represented as * for p,0.05; ** for p,0.01; and *** for
p,0.001.
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